Terlakiren

CAS No. 119625-78-4

Terlakiren( —— )

Catalog No. M34445 CAS No. 119625-78-4

Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 770 In Stock
10MG 842 In Stock
25MG 946 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Terlakiren
  • Note
    Research use only, not for human use.
  • Brief Description
    Terlakiren (CP-80,794) is an orally active, potent renin inhibitor used in the study of neurological disorders related to hypertension.
  • Description
    Terlakiren (CP-80,794) is an orally active inhibitor of renin. Terlakiren inhibits the efficacy of human renin with an IC50 value of 0.7 nM. Terlakiren has potential applications in hypertension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119625-78-4
  • Formula Weight
    620.8
  • Molecular Formula
    C31H48N4O7S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](CC1=CC=CC=C1)(C(N[C@H](C(N[C@@H](CC2CCCCC2)[C@H](C(OC(C)C)=O)O)=O)CSC)=O)NC(=O)N3CCOCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fouda H, et al. Quantitative analysis by high-performance liquid chromatography atmospheric pressure chemical ionization mass spectrometry: The determination of the renin inhibitor CP-80,794 in human serum. J Am Soc Mass Spectrom. 1991 Apr;2(2):164-7. ?
molnova catalog
related products
  • OPHIOPOGONIN D

    Ophiopogonin D is a natural productand is a CYP2J3 inducer that significantly inhibits Ang II induced NF-κB nuclear translocation.

  • FPL-62129

    FPL-62129 is a calcium channel antagonist and a novel angiotensin-converting enzyme inhibitor with vasodilator activity for the study of cardiovascular disease.

  • Ripisartan

    Ripisartan (UP-269-6) is a potent and specific angiotensin II receptor antagonist that inhibits angiotensin II-mediated sympathetic tachycardia responses.